Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome
Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1557-1558
DOI: 10.1111/apt.70626 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 25.03.2026. Verfasst von Kevin Whelan. Beteiligte Einrichtung: King's College London, Department of Nutritional Sciences, London, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- King's College London, Department of Nutritional Sciences, London, UK.
ORCID-Profile: Kevin Whelan
Zitieren
APA
Whelan, K. (2026). Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Alimentary Pharmacology & Therapeutics, 63(11), 1557-1558. https://doi.org/10.1111/apt.70626
Vancouver
Whelan K. Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Alimentary Pharmacology & Therapeutics. 2026;63(11):1557-1558. doi:10.1111/apt.70626
BibTeX
@article{Whelan2026,
author = {Whelan, Kevin},
title = {Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {11},
pages = {1557--1558},
doi = {10.1111/apt.70626}
}
EUVIMED